WallStreetZenWallStreetZen

NASDAQ: SRGA
Surgalign Holdings Inc Stock

$2.12+0.08 (+3.92%)
Updated Jan 27, 2023
SRGA Price
$2.12
Fair Value Price
$4.09
Market Cap
$14.32M
52 Week Low
$1.34
52 Week High
$21.45
P/E
-0.16x
P/B
1.16x
P/S
0.28x
PEG
N/A
Dividend Yield
N/A
Revenue
$83.24M
Earnings
-$60.86M
Gross Margin
66.6%
Operating Margin
-71.71%
Profit Margin
-73.1%
Debt to Equity
5.3
Operating Cash Flow
-$56M
Beta
1.05
Next Earnings
Mar 13, 2023
Ex-Dividend
N/A
Next Dividend
N/A

SRGA Overview

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SRGA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SRGA ($2.12) is undervalued by 48.22% relative to our estimate of its Fair Value price of $4.09 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SRGA ($2.12) is significantly undervalued by 48.22% relative to our estimate of its Fair Value price of $4.09 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SRGA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SRGA due diligence checks available for Premium users.

Be the first to know about important SRGA news, forecast changes, insider trades & much more!

SRGA News

Valuation

SRGA fair value

Fair Value of SRGA stock based on Discounted Cash Flow (DCF)
Price
$2.12
Fair Value
$4.09
Undervalued by
48.22%
SRGA ($2.12) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SRGA ($2.12) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SRGA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SRGA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.16x
Industry
57.58x
Market
23.59x

SRGA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.16x
Industry
3.56x
SRGA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SRGA's financial health

Profit margin

Revenue
$20.2M
Net Income
-$9.8M
Profit Margin
-48.7%
SRGA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SRGA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$88.0M
Liabilities
$65.7M
Debt to equity
5.3
SRGA's short-term assets ($66.65M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SRGA's short-term assets ($66.65M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SRGA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SRGA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.4M
Investing
-$2.3M
Financing
-$7.0k
SRGA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SRGA vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
SRGA$14.32M+3.92%-0.16x1.16x
STRR$13.73M+0.78%-0.65x0.34x
INBS$15.03M-14.69%-1.52x2.89x
SIEN$16.56M+5.81%-0.15x-3.82x
IINN$16.65M+4.43%-2.62x0.94x

Surgalign Holdings Stock FAQ

What is Surgalign Holdings's quote symbol?

NASDAQ: SRGA) Surgalign Holdings trades on the NASDAQ under the ticker symbol SRGA. Surgalign Holdings stock quotes can also be displayed as NASDAQ: SRGA.

If you're new to stock investing, here's how to buy Surgalign Holdings stock.

What is the 52 week high and low for Surgalign Holdings (NASDAQ: SRGA)?

(NASDAQ: SRGA) Surgalign Holdings's 52-week high was $21.45, and its 52-week low was $1.34. It is currently -90.12% from its 52-week high and 58.21% from its 52-week low.

How much is Surgalign Holdings stock worth today?

(NASDAQ: SRGA) Surgalign Holdings currently has 6,754,360 outstanding shares. With Surgalign Holdings stock trading at $2.12 per share, the total value of Surgalign Holdings stock (market capitalization) is $14.32M.

Surgalign Holdings stock was originally listed at a price of $421.80 in Aug 10, 2000. If you had invested in Surgalign Holdings stock at $421.80, your return over the last 22 years would have been -99.5%, for an annualized return of -21.38% (not including any dividends or dividend reinvestments).

How much is Surgalign Holdings's stock price per share?

(NASDAQ: SRGA) Surgalign Holdings stock price per share is $2.12 today (as of Jan 27, 2023).

What is Surgalign Holdings's Market Cap?

(NASDAQ: SRGA) Surgalign Holdings's market cap is $14.32M, as of Jan 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Surgalign Holdings's market cap is calculated by multiplying SRGA's current stock price of $2.12 by SRGA's total outstanding shares of 6,754,360.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.